Biblio

Export 60 results:
Author Title Type Year
Filters: Keyword is Mental Status Schedule  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Mental Status Schedule
A. Koppara, Wolfsgruber, S., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., Peters, O., Reischies, F. M., Jahn, H., Luckhaus, C., Hüll, M., Gertz, H. - J., Schröder, J., Pantel, J., Rienhoff, O., Rüther, E., Henn, F., Wiltfang, J., Maier, W., Jessen, F., Kornhuber, J., and Wagner, M., The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 49, no. 2, pp. 547-60, 2016.
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C., An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease., Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease., Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
M. Sattlecker, Khondoker, M., Proitsi, P., Williams, S., Soininen, H., Kłoszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., and Dobson, R. Jb, Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1105-14, 2016.
M. Babić Leko, Borovečki, F., Dejanović, N., Hof, P. R., and Šimić, G., Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 3, pp. 765-78, 2016.
A. Montesanto, Crocco, P., Anfossi, M., Smirne, N., Puccio, G., Colao, R., Maletta, R., Passarino, G., Bruni, A. C., and Rose, G., The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers., J Alzheimers Dis, vol. 51, no. 4, pp. 1265-74, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
D. R. Royall, Palmer, R. F., Matsuoka, T., Kato, Y., Taniguchi, S., Ogawa, M., Fujimoto, H., Okamura, A., Shibata, K., Nakamura, K., Nakaaki, S., Koumi, H., Mimura, M., Fukui, K., and Narumoto, J., δ Scores are Exportable Across Cultural and Linguistic Boundaries., J Alzheimers Dis, vol. 49, no. 2, pp. 561-70, 2016.
J. - P. Coutu, Goldblatt, A., H Rosas, D., and Salat, D. H., White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People., J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
A. Johnen, Frommeyer, J., Modes, F., Wiendl, H., Duning, T., and Lohmann, H., Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles., J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
K. Miwa, Tanaka, M., Okazaki, S., Yagita, Y., Sakaguchi, M., Mochizuki, H., and Kitagawa, K., Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors., J Alzheimers Dis, vol. 49, no. 2, pp. 503-13, 2016.
K. C. Fraser, Meltzer, J. A., and Rudzicz, F., Linguistic Features Identify Alzheimer's Disease in Narrative Speech., J Alzheimers Dis, vol. 49, no. 2, pp. 407-22, 2016.
H. - D. Tang, Zhou, Y., Gao, X., Liang, L., Hou, M. - M., Qiao, Y., Ma, J. - F., and Di Chen, S. -, Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study., J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
I. W. M. van Uden, van der Holst, H. M., Tuladhar, A. M., van Norden, A. G. W., de Laat, K. F., Rutten-Jacobs, L. C. A., Norris, D. G., Claassen, J. A. H. R., van Dijk, E. J., Kessels, R. P. C., and de Leeuw, F. - E., White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study., J Alzheimers Dis, vol. 49, no. 3, pp. 863-73, 2016.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
J. Liu, Zhang, X., Yu, C., Duan, Y., Zhuo, J., Cui, Y., Liu, B., Li, K., Jiang, T., and Liu, Y., Impaired Parahippocampus Connectivity in Mild Cognitive Impairment and Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1051-64, 2016.
E. M. Arroyo-Anlló, Bouston, A. Turpin, Fargeau, M. - N., Baz, B. Orgaz, and Gil, R., Self-Consciousness in Patients with Behavioral Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 49, no. 4, pp. 1021-9, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial., J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
G. Sacco, Caillaud, C., Ben Sadoun, G., Robert, P., David, R., and Brisswalter, J., Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
S. Lynn Lim, Gao, Q., Nyunt, M. Shwe Zin, Gong, L., Lunaria, J. B., Lim, M. Li, Ling, A., Lam, C. Su- Ping, Richards, A. Mark, Ling, L. Hsi, and Ng, T. Pin, Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies., J Alzheimers Dis, vol. 50, no. 1, pp. 27-40, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia., J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.

Pages